Account
Sign In
Home
Daily Diary
Asset Class
Fixed Income
Currencies
US Equity
Specialty
Global Equity & Income
Commodities
Sectors
Healthcare
Financial Services
Basic Materials
Consumer Cyclicals
Telecom Services
Energy
Transportation
Consumer Staples
Industrials
Utilities
Technology
Real Estate
Latest
Columnist Conversation
Video
Street Notes
Authors
Bruce Kamich
Jim Cramer
Jim "Rev Shark" DePorre
Brian Sozzi
Helene Meisler
Jonathan Heller
Roger Arnold
- See All -
Options
RMPIA
Switch Product
Action Alerts PLUS
Daily Swing Trade Archive
Income Seeker
Quant Ratings
Retirement
Stocks Under $10
TheStreet
Top Stocks
Trifecta Stocks
Information Provided By:
Visit TheFly.com
TheFly.com Free Trial
Fly News Breaks for February 13, 2017
BLRX
Get Breaking Institutional Stock News For
Free
with a 14 day trial
BioLineRx initiated with a Buy at Rodman & Renshaw
Feb 13, 2017 | 07:11 EDT
Rodman & Renshaw analyst Joseph Pantginis started BioLineRx with a Buy rating and $3 price target.
News For BLRX From the Last 2 Days
BLRX
Get Breaking Institutional Stock News For
Free
with a 14 day trial
Biotech Alert: Searches spiking for these stocks today
Mar 28, 2024 | 10:59 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Altamira Therapeutics... To see the rest of the story go to thefly.com.
See Story Here